Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
The company will address these observations within the stipulated timeline
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
